Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Nelson Syndrome

cabergoline has been researched along with Nelson Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casulari, LA; Mello, PA; Naves, LA; Papadia, C; Pereira Neto, A1
Shimon, I; Shraga-Slutzky, I; Weinshtein, R1
Colao, A; Di Salle, F; Faggiano, A; Filippella, M; Lombardi, G; Pivonello, R1

Other Studies

3 other study(ies) available for cabergoline and Nelson Syndrome

ArticleYear
Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Hormone research, 2004, Volume: 62, Issue:6

    Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Cyproheptadine; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Nelson Syndrome; Pituitary Neoplasms

2004
Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment.
    Pituitary, 2006, Volume: 9, Issue:2

    Topics: Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Middle Aged; Nelson Syndrome; Treatment Outcome

2006
Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.
    Journal of endocrinological investigation, 1999, Volume: 22, Issue:11

    Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Nelson Syndrome; Pituitary Neoplasms; Remission Induction

1999